Regulation of GDF-8 signaling by the p38 MAPK

被引:114
作者
Philip, B [1 ]
Lu, ZJ [1 ]
Gao, YJ [1 ]
机构
[1] Wyeth Res, Prot Technol Grp, Cambridge, MA 02140 USA
关键词
GDF-8; p38; MAPK; SMAD proteins; TGF-beta; cell cycle; p21;
D O I
10.1016/j.cellsig.2004.08.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Growth differentiation factor-8 (GDF-8), a member of the TGF-beta super-family. is a negative regulator of skeletal muscle growth. which functions through activation of the Smad proteins. We found that GDF-8 can activate the p38 mitogen-activated protein kinase (MAPK) through the TGF-beta-activated kinase I (TAK1), and this appeared to be independent of Smad signaling. GDF-8-induced transcriptional activation was inhibited by expression of dominant negative MKK6 or treatment with the p38 inhibitor SB203580. while overexpression of wild-type forms of either MKK6 or p38 augmented GDF-8-induced transcriptional activity. In addition. ATF-2, a known transcription factor target of p38, was found to be phosphorylated on GDF-8 stimulation and was detected in a complex with Smad3/Smad4 upon GDF-8 treatment. Furthermore, we found that the p38 MAPK played an important role in GDF-8-induced 6 inhibition of proliferation and upregulation of the cyclin kinase inhibitor p21. Together. these results highlight a functional link the p38 MAPK and GDF-8-activated Smad pathways, and identify a critical role for the p38 MAPK in GDF-8's function as a negative regulator of muscle growth. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:365 / 375
页数:11
相关论文
共 49 条
[1]  
Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322
[2]  
Aiyar A, 1996, Methods Mol Biol, V57, P177
[3]   Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling [J].
Atfi, A ;
Djelloul, S ;
Chastre, E ;
Davis, RR ;
Gespach, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :1429-1432
[4]  
Cardoso M. C., 1995, CELL CYCLE MAT METHO, P15
[5]   A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor β receptor [J].
Charng, MJ ;
Zhang, D ;
Kinnunen, P ;
Schneider, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9365-9368
[6]   The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin [J].
Cocolakis, E ;
Lemay, S ;
Ali, S ;
Lebrun, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18430-18436
[8]  
Dai JL, 1999, MOL CARCINOGEN, V26, P37, DOI 10.1002/(SICI)1098-2744(199909)26:1<37::AID-MC5>3.0.CO
[9]  
2-6
[10]   Transforming growth factor-β-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA [J].
Edlund, S ;
Landström, M ;
Heldin, CH ;
Aspenström, P .
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (03) :902-914